← Back to Screener
Allurion Technologies, Inc. (ALUR)
Price$0.80
Favorite Metrics
Price vs S&P 500 (26W)-68.75%
Price vs S&P 500 (4W)-1.24%
Market Capitalization$12.00M
All Metrics
Book Value / Share (Quarterly)$-1.11
Revenue Growth (3Y)-5.66%
Cash Flow / Share (Quarterly)$0.70
Price vs S&P 500 (YTD)-39.10%
Gross Margin (TTM)60.99%
Net Profit Margin (TTM)-199.95%
EPS (TTM)$-9.20
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-9.20
EPS (Annual)$-11.64
ROI (Annual)-39.99%
Gross Margin (Annual)66.97%
Cash / Share (Quarterly)$0.79
Revenue Growth QoQ (YoY)-50.48%
ROA (Last FY)-79.69%
Revenue Growth TTM (YoY)-50.49%
EBITD / Share (TTM)$-5.18
Operating Margin (TTM)-241.97%
Cash Flow / Share (Annual)$-15.83
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.21x
Net Interest Coverage (TTM)-7.45x
ROA (TTM)-117.10%
EPS Incl Extra (Annual)$-11.64
Current Ratio (Annual)1.44x
Quick Ratio (Quarterly)0.87x
3-Month Avg Trading Volume1.85M
52-Week Price Return-64.44%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-1.11
P/S Ratio (Annual)0.37x
Asset Turnover (Annual)0.98x
52-Week High$3.42
EPS Excl Extra (Annual)$-11.64
26-Week Price Return-60.00%
Quick Ratio (Annual)1.19x
13-Week Price Return-54.42%
Total Debt / Equity (Annual)5.40x
Current Ratio (Quarterly)1.26x
Enterprise Value$38.1
Asset Turnover (TTM)0.59x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.22x
Pretax Margin (Annual)-79.20%
Cash / Share (Annual)$5.67
3-Month Return Std Dev274.76%
Net Income / Employee (TTM)$-0
ROE (Last FY)-255.99%
Net Interest Coverage (Annual)-2.06x
EPS Basic Excl Extra (Annual)$-11.64
Receivables Turnover (TTM)2.47x
EV / Free Cash Flow (TTM)7.06x
EPS Incl Extra (TTM)$-9.20
Receivables Turnover (Annual)2.54x
P/S Ratio (TTM)0.70x
Revenue / Share (Annual)$14.29
Tangible BV / Share (Annual)$-0.76
Price vs S&P 500 (52W)-99.54%
Year-to-Date Return-34.96%
5-Day Price Return-11.01%
EPS Normalized (Annual)$-11.64
Net Profit Margin (Annual)-81.43%
Month-to-Date Return18.52%
Cash Flow / Share (TTM)$-1.74
EBITD / Share (Annual)$-25.37
Operating Margin (Annual)-183.47%
LT Debt / Equity (Annual)0.41x
P/CF (TTM)2.22x
EPS Basic Excl Extra (TTM)$-9.20
Inventory Turnover (TTM)1.63x
Pretax Margin (TTM)-196.15%
Book Value / Share (Annual)$-0.76
Price vs S&P 500 (13W)-57.28%
Beta-0.07x
Revenue / Share (TTM)$2.22
52-Week Low$0.23
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.25
4.25
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ALURAllurion Technologies, Inc. | 0.70x | — | 60.99% | -241.97% | $0.80 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Allurion Technologies develops a minimally invasive weight loss platform centered on the Allurion Balloon, a swallowable intragastric balloon that requires no surgery, endoscopy, or anesthesia. The platform combines the proprietary balloon with AI-powered remote patient monitoring, a behavior modification program, and virtual care services delivered through its proprietary Allurion VCS. This non-procedural approach addresses a significant market opportunity in weight management for overweight patients seeking alternatives to invasive interventions.